Revolution Medicines gets FDA nod for targeted pancreatic cancer drug
- Posted on August 26, 2026
- By CNN
- 0 Views
- 1 min read
In brief
Generating AI summary…
Revolution Medicines gets FDA nod for targeted pancreatic cancer drug
The U.S. Food and Drug Administration on Wednesday approved Revolution Medicines’ targeted drug for adults with metastatic pancreatic cancer who have received prior treatment or cannot receive combination chemotherapy.
